Physician profile
Robert K Masters
NPI 1871685214
$16,384.63
in general payments reported to CMS, 2019-2025
51 companies · $2,683 in 2025
The $2,683 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,789 · 2020: $1,766 · 2021: $3,027 · 2022: $2,783 · 2023: $2,103 · 2024: $1,235 · 2025: $2,683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,955 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,955.07 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $3,434.85 | 2019-2025 | Orsiro Mission, Amvia Edge, Biomonitor |
| Aop Health US, LLC | $1,290.39 | 2025 | Rapiblyk |
| Novartis Pharmaceuticals Corporation | $976.67 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $858.36 | 2019-2025 | Lifevest |
| Amgen INC. | $705.27 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $599.21 | 2019-2025 | Jardiance |
| Impulse Dynamics (USA) INC. | $598.34 | 2022-2023 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $580.26 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $578.72 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Boston Scientific Corporation | $537.96 | 2019-2024 | Rotapro, Watchman Access System, Bodyguardian |
| Acutus Medical, INC. | $519.63 | 2019-2022 | |
| Novo Nordisk INC | $462.17 | 2022-2025 | Ozempic, Wegovy |
| Sanofi-Aventis U.S. LLC | $438.03 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $408.11 | 2019-2023 | Farxiga, Andexxa |
| Janssen Pharmaceuticals, INC | $406.98 | 2019-2024 | Xarelto |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $318.47 | 2019-2023 | Jot Dx, Amplatzer Amulet, Cardiomems |
| Astellas Pharma US INC | $308.55 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $299.04 | 2021-2025 | Amvuttra |
| Amarin Pharma, INC. | $298.54 | 2019-2021 | |
| Chiesi USA, INC. | $292.94 | 2019-2025 | Kengreal |
| Esperion Therapeutics, INC. | $238.98 | 2020-2024 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $220.01 | 2019-2021 | |
| Pfizer INC. | $202.61 | 2020-2025 | |
| Cvrx, INC. | $175.48 | 2021-2023 | Barostim Neo System |
| Scpharmaceuticals INC. | $171.03 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $151.34 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $143.56 | 2021-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $135.47 | 2021-2023 | Arcalyst |
| Atricure, INC. | $126.19 | 2022-2025 | Atriclip Laa Exclusion System |
| Otsuka America Pharmaceutical, INC. | $94.71 | 2019 | |
| Azurity Pharmaceuticals, INC. | $91.93 | 2023-2025 | Edarbi, Edarbyclor, Edarbi |
| Actelion Pharmaceuticals US, INC. | $82.60 | 2025 | Uptravi, Opsumit |
| Altathera Pharmaceuticals LLC | $67.65 | 2025 | Sotalol Hydrochloride |
| Arbor Pharmaceuticals, INC. | $64.10 | 2021-2022 | |
| Tactile Systems Technology INC | $59.94 | 2020-2022 | |
| Kestra Medical Technology Services, INC. | $56.09 | 2022-2024 | Assure Wcd |
| Abiomed | $46.76 | 2021-2025 | |
| Gilead Sciences, INC. | $45.93 | 2019 | |
| Philips North America LLC | $40.23 | 2020-2025 | (Bs2) Lm Undivided, Ice 3d |
| Cardiofocus, INC. | $30.45 | 2023 | Heartlight System |
| Cleerly, INC. | $27.83 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Medtronic, INC. | $24.58 | 2021-2022 | |
| Celgene Corporation | $24.06 | 2023 | Camzyos |
| Cardiovascular Systems INC. | $23.56 | 2019 | |
| Inari Medical, INC. | $22.64 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Preventice Services, LLC | $20.72 | 2021 | |
| Infobionic, INC | $20.51 | 2022 | |
| Medtronic Vascular, INC. | $19.37 | 2019 | |
| Cardiva Medical, INC. | $15.98 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Lundbeck LLC | $14.26 | 2020 | |
| Itamar Medical INC | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Masters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.